Pharma R&D Pipeline Reached
R&D pipelines and new product launches reached record levels last year with sustained growth throughout the pandemic creating very positive figures for 2021. This is according to a new report that showed 5,500 planned new clinical trials began in 2021, a 14% increase on the year before. Not only that but the total volume of products that were actively being developed last year peaked at more than 6,000. This is a huge increase on previous years - for example, it's...
View full press release